1. White AC Jr. Neurocysticercosis: Updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med. 2000; 51:187–206.
2. Kong Y, Cho SY, Cho MS, Kwon OS, Kang WS. Seroepidemiological observation of taenia solium cysticercosis in epileptic patients in Korea. J Korean Med Sci. 1993; 8:145–152.
3. Escobar A. The pathology of neurocysticercosis. In : Palacios E, Rodriguez-Carbajal J, Taveras JM, editors. Cysticercosis of the central nervous system. Springfield, III: Charles C. Thomas;1983. p. 27–54.
4. Hawk MW, Shahlaie K, Kim KD, Theis JH. Neurocysticercosis: a review. Surg Neurol. 2005; 63:123–132.
5. Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003; 87:71–78.
6. Sheth TN, Pillon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol. 1998; 19:79–82.
7. Sheth TN, Lee C, Kucharczyk W, Keystone J. Reactivation of neurocysticercosis: case report. Am J Trop Med Hyg. 1999; 60:664–667.